Methylenetetrahydrofolate Reductase C677T and A1298C Polymorphisms and Gastric Cancer: A Meta-analysis

Archives of Medical Research

Volumn 41, Issue 2, 2010, Pages 125-133

  Dong, Xingli ^a,c   Wu, Jianing ^b   Liang, Peng ^b   Li, Jihong ^a,c   Yuan, Lijie ^a,c   Liu, Xinghan ^a,c  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^c Department of Pharmacology and Bio pharmaceutical   (China)

Author keywords

A1298C; C677T; Gastric cancer; Meta analysis; MTHFR

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ALANINE; CYSTEINE; THREONINE;

ARTICLE; ASIAN; CANCER RISK; CANCER SUSCEPTIBILITY; CAUCASIAN; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HOMOZYGOSITY; HUMAN; RISK ASSESSMENT; STOMACH CANCER;

CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, GENETIC; PUBMED; STOMACH NEOPLASMS;

EID: 77952890994     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2010.01.001     Document Type: Article

References (54)

1. Crew K.D., Neugut A.I. Epidemiology of gastric cancer. World J Gastroenterol 2006, 12:354-362.
2. Torres J., Lopez L., Lazcano E., et al. Trends in Helicobacter pylori infection and gastric cancer in Mexico. Cancer Epidemiol Biomarkers Prev 2005, 14:1874-1877.
3. Gonzalez C.A., Sala N., Capella G. Genetic susceptibility and gastric cancer risk. Int J Cancer 2002, 100:249-260.
4. Zhang F.F., Terry M.B., Hou L., et al. Genetic polymorphisms in folate metabolism and the risk of stomach cancer. Cancer Epidemiol Biomarkers Prev 2007, 16:115-121.
5. Stern L.L., Mason J.B., Selhub J., et al. Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene. Cancer Epidemiol Biomarkers Prev 2000, 9:849-853.
6. Frosst P., Blom H.J., Milos R., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995, 10:111-113.
7. Weisberg I., Tran P., Christensen B., et al. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 1998, 64:169-172.
8. Rozen R. Genetic predisposition to hyperhomocysteinemia: deficiency of methylenetetrahydrofolate reductase (MTHFR). Thromb Haemost 1997, 78:523-526.
9. Parle-McDermott A., Mills J.L., Molloy A.M., et al. The MTHFR 1298CC and 677TT genotypes have opposite associations with red cell folate levels. Mol Genet Metab 2006, 88:290-294.
10. Friedman G., Goldschmidt N., Friedlander Y., et al. A common mutation A1298C in human methylenetetrahydrofolate reductase gene: association with plasma total homocysteine and folate concentrations. J Nutr 1999, 129:1656-1661.
11. Klerk M., Verhoef P., Clarke R., et al. MTHFR 677C/T polymorphism and risk of coronary heart disease: a metaanalysis. JAMA 2002, 288:2023-2031.
12. Lievers K.J., Boers G.H., Verhoef P., et al. A second common variant in the methylenetetrahydrofolate reductase (MTHFR) gene and its relationship to MTHFR enzyme activity, homocysteine, and cardiovascular disease risk. J Mol Med 2001, 79:522-528.
13. Chango A., Boisson F., Barbe F., et al. The effect of 677C/T and 1298A/C mutations on plasma homocysteine and 5,10-methylenetetrahydrofolate reductase activity in healthy subjects. Br J Nutr 2000, 83:593-596.
14. Zintzaras E., Ioannidis J.P. Heterogeneity testing in meta-analysis of genome searches. Genet Epidemiol 2005, 28:123-137.
15. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21:1539-1558.
16. Lau J., Ioannidis J.P., Schmid C.H. Quantitative synthesis in systematic reviews. Ann Intern Med 1997, 127:820-826.
17. Harbord R.M., Egger M., Sterne J.A. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Statist Med 2006, 25:3443-3457.
18. Gao C.M., Lu J.W., Toshiro T., et al. Polymorphism of methylenetetrahydrofolate reductase and sensitivity of stomach cancer to fluoropyrimidine-based chemotherapy. Zhonghua Liu Xing Bing Xue Za Zhi 2004, 25:1054-1058.
19. Gao C.M., Takezaki T., Wu J.Z., et al. Polymorphisms in thymidylate synthase and methylenetetrahydrofolate reductase genes and the susceptibility to esophageal and stomach cancer with smoking. Asian Pac J Cancer Prev 2004, 5:133-138.
20. Gao C.M., Wu J.Z., Liu Y.T., et al. Interactions between lifestyle, methylanetetrahydrofolate reductase gene and polymorphisms in thymidylate synthase gene with risk of stomach cancer. Zhonghua Liu Xing Bing Xue Za Zhi 2003, 24:599-603.
21. Mu L.N., Ding B.G., Chen C.W., et al. A case-control study on the relationship between methyl-tetra-hydrofolic acid reductase 677 gene polymorphism and the risk of stomach cancer. Zhonghua Liu Xing Bing Xue Za Zhi 2004, 25:495-498.
22. Miao X., Xing D., Tan W., et al. Single nucleotide polymorphisms in methylenetetrahydrofolate reductase gene and susceptibility to cancer of the gastric cardia in Chinese population. Zhonghua Yi Xue Za Zhi 2002, 82:669-672.
23. Shen H., Xu Y., Zheng Y., et al. Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population: a case-control study. Int J Cancer 2001, 95:332-336.
24. Gao C., Wu J., Ding J., et al. Polymorphisms of methylenetetrahydrofolate reductase C677T and the risk of stomach cancer. Zhonghua Liu Xing Bing Xue Za Zhi 2002, 23:289-292.
25. Mu L.N., Cao W., Zhang Z.F., et al. Polymorphisms of 5,10-methylenetetralydrofolate reductase (MTHFR), fruit and vegetable intake, and the risk of stomach cancer. Biomarkers 2007, 12:61-75.
26. Miao X., Xing D., Tan W., et al. Susceptibility to gastric cardia adenocarcinoma and genetic polymorphisms in methylenetetrahydrofolate reductase in an at-risk Chinese population. Cancer Epidemiol Biomarkers Prev 2002, 11:1454-1458.
27. Shen H., Newmann A.S., Hu Z., et al. Methylenetetrahydrofolate reductase polymorphisms/haplotypes and risk of gastric cancer: a case-control analysis in China. Oncol Rep 2005, 13:355-360.
28. Bi J.P., Cai L., Zheng Z.L. Study on C667T gene polymorphism and susceptibility to gastric cancer. Chin J Public Health 2005, 21:661-663.
29. Sun L., Sun Y.H., Wang B., et al. Methylenetetrahydrofolate reductase polymorphisms and susceptibility to gastric cancer in Chinese populations: a meta-analysis. Eur J Cancer Prev 2008, 17:446-452.
30. Boccia S., Gianfagna F., Persiani R., et al. Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and susceptibility to gastric adenocarcinoma in an Italian population. Biomarkers 2007, 12:635-644.
31. Gotze T., Rocken C., Rohl F.W., et al. Gene polymorphisms of folate metabolizing enzymes and the risk of gastric cancer. Cancer Lett 2007, 251:228-236.
32. Graziano F., Kawakami K., Ruzzo A., et al. Methylenetetrahydrofolate reductase 677C/T gene polymorphism, gastric cancer susceptibility and genomic DNA hypomethylation in an at-risk Italian population. Int J Cancer 2006, 118:628-632.
33. Sarbia M., Geddert H., Kiel S., et al. Methylenetetrahydrofolate reductase C677T polymorphism and risk of adenocarcinoma of the upper gastrointestinal tract. Scand J Gastroenterol 2005, 40:109-111.
34. Li S., Ji M., He N., et al. Application of microarray-based method for methylenetetrahydrofolate reductase (MTHFR) polymorphisms in the risk of gastric carcinoma in east China population. J Nanosci Nanotechnol 2007, 7:3245-3249.
35. Wang Y., Guo W., He Y., et al. Association of MTHFR C677T and SHMT(1) C1420T with susceptibility to ESCC and GCA in a high incident region of Northern China. Cancer Causes Control 2007, 18:143-152.
36. Weng Y.R., Sun D.F., Fang J.Y., et al. Folate levels in mucosal tissue but not methylenetetrahydrofolate reductase polymorphisms are associated with gastric carcinogenesis. World J Gastroenterol 2006, 12:7591-7597.
37. Si P.R., Fang D.C., Zhang H., et al. The relationship between methylenetetrahydrofolate reductase gene polymorphism and microsatellite instability in gastric cancer. Zhonghua Liu Xing Bing Xue Za Zhi 2005, 26:794-799.
38. Kim J.K., Kim S., Han J.H., et al. Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of stomach cancer in a Korean population. Anticancer Res 2005, 25:2249-2252.
39. Wang L.D., Guo R.F., Fan Z.M., et al. Association of methylenetetrahydrofolate reductase and thymidylate synthase promoter polymorphisms with genetic susceptibility to esophageal and cardia cancer in a Chinese high-risk population. Dis Esophagus 2005, 18:177-184.
40. 12-related polymorphisms in Linxian, China. Cancer Epidemiol Biomarkers Prev 2003, 12:1222-1226.
41. Galvan-Portillo M.V., Cantoral A., Onate-Ocana L.F., et al. Gastric cancer in relation to the intake of nutrients involved in one-carbon metabolism among MTHFR 677 TT carriers. Eur J Nutr 2009, 48:269-276.
42. Zuniga-Noriega J.R., Velazco-Campos M., del R., Aguirre-Rodriguez A., et al. C677T polymorphism of the MTHFR gene and the risk of developing distal gastric cancer in a Mexican population. Rev Gastroenterol Mex 2007, 72:355-358.
43. Lacasana-Navarro M., Galvan-Portillo M., Chen J., et al. Methylenetetrahydrofolate reductase 677C >T polymorphism and gastric cancer susceptibility in Mexico. Eur J Cancer 2006, 42:528-533.
44. Vollset S.E., Igland J., Jenab M., et al. The association of gastric cancer risk with plasma folate, cobalamin, and methylenetetrahydrofolate reductase polymorphisms in the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev 2007, 16:2416-2424.
45. Zeybek U., Yaylim I., Yilmaz H., et al. Methylenetetrahydrofolate reductase C677T polymorphism in patients with gastric and colorectal cancer. Cell Biochem Funct 2007, 25:419-422.
46. Boccia S., Hung R., Ricciardi G., et al. Meta- and pooled analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer risk: a huge-GSEC review. Am J Epidemiol 2008, 167:505-516.
47. Zintzaras E. Association of methylenetetrahydrofolate reductase (MTHFR) polymorphisms with genetic susceptibility to gastric cancer: a meta-analysis. J Hum Genet 2006, 51:618-624.
48. Larsson S.C., Giovannucci E., Wolk A. Folate intake, MTHFR polymorphisms, and risk of esophageal, gastric, and pancreatic cancer: a meta-analysis. Gastroenterology 2006, 131:1271-1283.
49. Kamen B. Folate and antifolate pharmacology. Semin Oncol 1997, 24. S18-30-S18-39.
50. Zintzaras E. Methylenetetrahydrofolate reductase gene and susceptibility to breast cancer: a meta-analysis. Clin Genet 2006, 69:327-3361.
51. Song C., Xing D., Tan W., et al. Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res 2001, 61:3272-3275.
52. Fodinger M., Horl W.H., Sunder-Plassmann G. Molecular biology of 5,10-methylenetetrahydrofolate reductase. J Nephrol 2000, 13:20-33.
53. Frosst P., Blom H.J., Milos R., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995, 10:111-113.
54. Bailey L.B. Folate status assessment. J Nutr 1990, 120(Suppl):1508-1511.